Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
Aged
Alzheimer Disease
/ diagnosis
Amyloid beta-Peptides
/ cerebrospinal fluid
Biomarkers
/ cerebrospinal fluid
Cognitive Dysfunction
/ diagnosis
Cross-Sectional Studies
Disease Progression
Female
Humans
Male
Neuropsychological Tests
Peptide Fragments
/ cerebrospinal fluid
Retrospective Studies
tau Proteins
/ cerebrospinal fluid
Alzheimer’s disease
CSF biomarkers
Cognitive impairment
Mild cognitive impairment
Neuropsychiatric symptoms
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
15
08
2018
accepted:
12
03
2019
pubmed:
25
3
2019
medline:
14
1
2020
entrez:
24
3
2019
Statut:
ppublish
Résumé
Alzheimer's disease (AD) is the most common form of dementia characterized by the prevalent memory impairment. Mild cognitive impairment (MCI) may represent the early stage of AD, in particular when MCI patients show biomarkers consistent with AD pathology (MCI due to AD). Neuropsychiatric symptoms (NPS) frequently affect both MCI and AD patients. Cerebrospinal-fluid (CSF) tau and β-amyloid
Identifiants
pubmed: 30903419
doi: 10.1007/s10072-019-03840-4
pii: 10.1007/s10072-019-03840-4
doi:
Substances chimiques
Amyloid beta-Peptides
0
Biomarkers
0
MAPT protein, human
0
Peptide Fragments
0
amyloid beta-protein (1-42)
0
tau Proteins
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1377-1382Références
Neurol Clin. 2000 Nov;18(4):829-46
pubmed: 11072263
Ann Neurol. 2001 Mar;49(3):355-61
pubmed: 11261510
JAMA. 2002 Sep 25;288(12):1475-83
pubmed: 12243634
Neurology. 2005 Nov 8;65(9):1502-3
pubmed: 16275849
Lancet Neurol. 2006 Mar;5(3):228-34
pubmed: 16488378
Arch Gen Psychiatry. 2006 May;63(5):530-8
pubmed: 16651510
Neurology. 2006 Nov 14;67(9):1575-80
pubmed: 16971697
Arch Neurol. 1991 Jun;48(6):619-24
pubmed: 1710105
Neurol Sci. 2007 Apr;28(2):96-9
pubmed: 17464473
Dement Geriatr Cogn Disord. 2007;24(4):253-9
pubmed: 17700021
Neurobiol Aging. 2009 May;30(5):682-90
pubmed: 17889968
Dement Geriatr Cogn Disord. 2008;25(6):559-63
pubmed: 18536520
Neurol Sci. 2009 Oct;30(5):367-73
pubmed: 19590821
Arch Neurol. 2010 Jun;67(6):688-96
pubmed: 20558388
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Alzheimers Dement. 2011 Sep;7(5):532-9
pubmed: 21889116
Psychol Med. 2013 May;43(5):911-20
pubmed: 22954311
Ann Neurol. 2013 Aug;74(2):199-208
pubmed: 23686697
J Alzheimers Dis. 2014;40(3):587-94
pubmed: 24496071
Alzheimers Dement. 2014 Nov;10(6):713-723.e2
pubmed: 24721526
J Neurol. 2014 Sep;261(9):1832-6
pubmed: 25119837
J Alzheimers Dis. 2015;48(3):627-36
pubmed: 26402103
Neurobiol Aging. 2016 Apr;40:120-126
pubmed: 26973111
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1686-99
pubmed: 26996778
Z Gerontol Geriatr. 2018 Aug;51(6):642-649
pubmed: 27342103
Hum Brain Mapp. 2016 Dec;37(12):4234-4247
pubmed: 27412866
Am J Geriatr Psychiatry. 2016 Nov;24(11):1095-1104
pubmed: 27426238
QJM. 2017 Sep 1;110(9):565-570
pubmed: 28383687
Neurology. 2017 May 9;88(19):1814-1821
pubmed: 28404803
Front Neurosci. 2017 Mar 31;11:167
pubmed: 28408865
J Alzheimers Dis. 2017;59(4):1439-1448
pubmed: 28731429
Neurol Sci. 2018 May;39(5):903-908
pubmed: 29508098
J Neuropsychiatry Clin Neurosci. 1995 Fall;7(4):476-84
pubmed: 8555751
Neurology. 1996 Jan;46(1):130-5
pubmed: 8559361
Neurology. 1997 May;48(5 Suppl 6):S10-6
pubmed: 9153155
Neuroreport. 1997 Dec 22;8(18):3961-3
pubmed: 9462474
Arch Neurol. 1998 Apr;55(4):539-44
pubmed: 9561983